<!DOCTYPE article
PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.2 20190208//EN" "JATS-archivearticle1-mathml3.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article"><front><journal-meta><journal-id journal-id-type="nlm-ta">Health Care Manag Sci</journal-id><journal-id journal-id-type="iso-abbrev">Health Care Manag Sci</journal-id><journal-title-group><journal-title>Health Care Management Science</journal-title></journal-title-group><issn pub-type="ppub">1386-9620</issn><issn pub-type="epub">1572-9389</issn><publisher><publisher-name>Springer US</publisher-name><publisher-loc>Boston</publisher-loc></publisher></journal-meta><article-meta><article-id pub-id-type="pmid">18074967</article-id><article-id pub-id-type="pmc">3428220</article-id><article-id pub-id-type="publisher-id">9027</article-id><article-id pub-id-type="doi">10.1007/s10729-007-9027-6</article-id><article-categories><subj-group subj-group-type="heading"><subject>Article</subject></subj-group></article-categories><title-group><article-title>Contact tracing to control infectious disease: when enough is enough</article-title></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><name><surname>Armbruster</surname><given-names>Benjamin</given-names></name><address><phone>+1-650-725-1623</phone><fax>+1-650-723-1614</fax><email>armbruster@stanford.edu</email></address><xref ref-type="aff" rid="Aff1"/></contrib><contrib contrib-type="author"><name><surname>Brandeau</surname><given-names>Margaret L.</given-names></name><xref ref-type="aff" rid="Aff1"/></contrib><aff id="Aff1"><institution-wrap><institution-id institution-id-type="GRID">grid.168010.e</institution-id><institution-id institution-id-type="ISNI">0000000419368956</institution-id><institution>Department of Management Science and Engineering, </institution><institution>Stanford University, </institution></institution-wrap>Stanford, CA 94305-4026 USA </aff></contrib-group><pub-date pub-type="epub"><day>3</day><month>10</month><year>2007</year></pub-date><pub-date pub-type="ppub"><year>2007</year></pub-date><volume>10</volume><issue>4</issue><fpage>341</fpage><lpage>355</lpage><history><date date-type="received"><day>30</day><month>3</month><year>2007</year></date><date date-type="accepted"><day>26</day><month>7</month><year>2007</year></date></history><permissions><copyright-statement>&#x000a9; Springer Science+Business Media, LLC 2007</copyright-statement><license><license-p>This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic.</license-p></license></permissions><abstract id="Abs1"><p>Contact tracing (also known as partner notification) is a primary means of controlling infectious diseases such as tuberculosis (TB), human immunodeficiency virus (HIV), and sexually transmitted diseases (STDs). However, little work has been done to determine the optimal level of investment in contact tracing. In this paper, we present a methodology for evaluating the appropriate level of investment in contact tracing. We develop and apply a simulation model of contact tracing and the spread of an infectious disease among a network of individuals in order to evaluate the cost and effectiveness of different levels of contact tracing. We show that contact tracing is likely to have diminishing returns to scale in investment: incremental investments in contact tracing yield diminishing reductions in disease prevalence. In conjunction with a cost-effectiveness threshold, we then determine the optimal amount that should be invested in contact tracing. We first assume that the only incremental disease control is contact tracing. We then extend the analysis to consider the optimal allocation of a budget between contact tracing and screening for exogenous infection, and between contact tracing and screening for endogenous infection. We discuss how a simulation model of this type, appropriately tailored, could be used as a policy tool for determining the appropriate level of investment in contact tracing for a specific disease in a specific population. We present an example application to contact tracing for chlamydia control.</p></abstract><kwd-group xml:lang="en"><title>Keywords</title><kwd>Contact tracing</kwd><kwd>Infectious disease</kwd><kwd>Network</kwd><kwd>Cost-effectiveness</kwd></kwd-group><custom-meta-group><custom-meta><meta-name>issue-copyright-statement</meta-name><meta-value>&#x000a9; Springer Science+Business Media, LLC 2007</meta-value></custom-meta></custom-meta-group></article-meta></front><back><ref-list id="Bib1"><title>References</title><ref id="CR1"><label>1.</label><mixed-citation publication-type="other">Saretok P, Brouwers L (2007) Microsimulation of pandemic influenza in Sweden. In: Proceedings of the 2007 western multiconference on computer simulation, pp 73&#x02013;78</mixed-citation></ref><ref id="CR2"><label>2.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bozzette</surname><given-names>SA</given-names></name><name><surname>Boer</surname><given-names>R</given-names></name><name><surname>Bhatnagar</surname><given-names>V</given-names></name><name><surname>Brower</surname><given-names>JL</given-names></name><name><surname>Keeler</surname><given-names>EB</given-names></name><name><surname>Morton</surname><given-names>SC</given-names></name><name><surname>Stoto</surname><given-names>MA</given-names></name></person-group><article-title>A model for a smallpox-vaccination policy</article-title><source>N Engl J Med</source><year>2003</year><volume>348</volume><issue>5</issue><fpage>416</fpage><lpage>425</lpage><pub-id pub-id-type="doi">10.1056/NEJMsa025075</pub-id><pub-id pub-id-type="pmid">12496353</pub-id></element-citation></ref><ref id="CR3"><label>3.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hethcote</surname><given-names>HW</given-names></name></person-group><article-title>Gonorrhea modeling: a comparison of control methods</article-title><source>Math Biosci</source><year>1982</year><volume>58</volume><fpage>93</fpage><lpage>109</lpage><pub-id pub-id-type="doi">10.1016/0025-5564(82)90053-0</pub-id></element-citation></ref><ref id="CR4"><label>4.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zaric</surname><given-names>GS</given-names></name><name><surname>Brandeau</surname><given-names>ML</given-names></name></person-group><article-title>Resource allocation for epidemic control over short time horizons</article-title><source>Math Biosci</source><year>2001</year><volume>171</volume><fpage>33</fpage><lpage>58</lpage><pub-id pub-id-type="doi">10.1016/S0025-5564(01)00050-5</pub-id><pub-id pub-id-type="pmid">11325383</pub-id></element-citation></ref><ref id="CR5"><label>5.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zaric</surname><given-names>GS</given-names></name><name><surname>Brandeau</surname><given-names>ML</given-names></name></person-group><article-title>Dynamic resource allocation for epidemic control in multiple populations</article-title><source>IMA J Math Appl Med Biol</source><year>2002</year><volume>19</volume><fpage>235</fpage><lpage>255</lpage><pub-id pub-id-type="doi">10.1093/imammb/19.4.235</pub-id><pub-id pub-id-type="pmid">12828363</pub-id></element-citation></ref><ref id="CR6"><label>6.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Longini</surname><given-names>IM</given-names><suffix>Jr</suffix></name><name><surname>Ackerman</surname><given-names>E</given-names></name><name><surname>Elveback</surname><given-names>L</given-names></name></person-group><article-title>An optimization model for influenza A epidemics</article-title><source>Math Biosci</source><year>1978</year><volume>38</volume><fpage>141</fpage><lpage>157</lpage><pub-id pub-id-type="doi">10.1016/0025-5564(78)90023-8</pub-id></element-citation></ref><ref id="CR7"><label>7.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Halloran</surname><given-names>ME</given-names></name><name><surname>Longini</surname><given-names>IM</given-names><suffix>Jr</suffix></name><name><surname>Nizam</surname><given-names>A</given-names></name><name><surname>Yang</surname><given-names>Y</given-names></name></person-group><article-title>Containing bioterrorist smallpox</article-title><source>Science</source><year>2002</year><volume>298</volume><issue>5597</issue><fpage>1428</fpage><lpage>1432</lpage><pub-id pub-id-type="doi">10.1126/science.1074674</pub-id><pub-id pub-id-type="pmid">12434061</pub-id></element-citation></ref><ref id="CR8"><label>8.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>M&#x000fc;ller</surname><given-names>J</given-names></name></person-group><article-title>Optimal vaccination patterns in age-structured populations</article-title><source>SIAM J Appl Math</source><year>1998</year><volume>59</volume><fpage>222</fpage><lpage>241</lpage><pub-id pub-id-type="doi">10.1137/S0036139995293270</pub-id></element-citation></ref><ref id="CR9"><label>9.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Revelle</surname><given-names>C</given-names></name><name><surname>Feldmann</surname><given-names>F</given-names></name><name><surname>Lynn</surname><given-names>W</given-names></name></person-group><article-title>An optimization model tuberculosis epidemiology</article-title><source>Manage Sci</source><year>1969</year><volume>16</volume><issue>4</issue><fpage>B190</fpage><lpage>B211</lpage></element-citation></ref><ref id="CR10"><label>10.</label><mixed-citation publication-type="other">Centers for Disease Control and Prevention (2000) Chapter 10&#x02014;community TB control: identification of persons who have clinically active TB, 2000. URL: <ext-link ext-link-type="uri" xlink:href="http://www.cdc.gov/nchstp/tb/pubs/corecurr/Chapter10/Chapter_10_Identification.htm">http://www.cdc.gov/nchstp/tb/pubs/corecurr/Chapter10/Chapter_10_Identification.htm</ext-link></mixed-citation></ref><ref id="CR11"><label>11.</label><mixed-citation publication-type="other">Centers for Disease Control and Prevention (2002) Sexually transmitted diseases treatment guidelines 2002. URL: <ext-link ext-link-type="uri" xlink:href="http://www.cdc.gov/STD/treatment/1-2002TG.htm">http://www.cdc.gov/STD/treatment/1-2002TG.htm</ext-link></mixed-citation></ref><ref id="CR12"><label>12.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cowan</surname><given-names>FM</given-names></name><name><surname>French</surname><given-names>R</given-names></name><name><surname>Johnson</surname><given-names>AM</given-names></name></person-group><article-title>The role and effectiveness of partner notification in STD control: a review</article-title><source>Genitourin Med</source><year>1996</year><volume>72</volume><fpage>247</fpage><lpage>252</lpage><pub-id pub-id-type="pmid">8976827</pub-id></element-citation></ref><ref id="CR13"><label>13.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Clarke</surname><given-names>J</given-names></name></person-group><article-title>Contact tracing for chlamydia: data on effectiveness</article-title><source>Int J STD AIDS</source><year>1998</year><volume>9</volume><fpage>187</fpage><lpage>191</lpage><pub-id pub-id-type="doi">10.1258/0956462981921945</pub-id><pub-id pub-id-type="pmid">9598743</pub-id></element-citation></ref><ref id="CR14"><label>14.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lipsitch</surname><given-names>M</given-names></name><name><surname>Cohen</surname><given-names>T</given-names></name><name><surname>Cooper</surname><given-names>B</given-names></name><name><surname>Robins</surname><given-names>JM</given-names></name><name><surname>Ma</surname><given-names>S</given-names></name><name><surname>James</surname><given-names>L</given-names></name><name><surname>Gopalakrishna</surname><given-names>G</given-names></name><name><surname>Chew</surname><given-names>SK</given-names></name><name><surname>Tan</surname><given-names>CC</given-names></name><name><surname>Samore</surname><given-names>MH</given-names></name><name><surname>Fisman</surname><given-names>D</given-names></name><name><surname>Murray</surname><given-names>M</given-names></name></person-group><article-title>Transmission dynamics and control of severe acute respiratory syndrome</article-title><source>Science</source><year>2003</year><volume>300</volume><issue>5627</issue><fpage>1966</fpage><lpage>1970</lpage><pub-id pub-id-type="doi">10.1126/science.1086616</pub-id><pub-id pub-id-type="pmid">12766207</pub-id></element-citation></ref><ref id="CR15"><label>15.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kiss</surname><given-names>IZ</given-names></name><name><surname>Green</surname><given-names>DM</given-names></name><name><surname>Kao</surname><given-names>RR</given-names></name></person-group><article-title>Disease contact tracing in random and clustered networks</article-title><source>Proc R Soc Lond B Biol Sci</source><year>2005</year><volume>272</volume><fpage>1407</fpage><lpage>1414</lpage><pub-id pub-id-type="doi">10.1098/rspb.2005.3092</pub-id></element-citation></ref><ref id="CR16"><label>16.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Porco</surname><given-names>TC</given-names></name><name><surname>Holbrook</surname><given-names>KA</given-names></name><name><surname>Fernyak</surname><given-names>SE</given-names></name><name><surname>Portnoy</surname><given-names>DL</given-names></name><name><surname>Reiter</surname><given-names>R</given-names></name><name><surname>Arag&#x000f3;n</surname><given-names>TJ</given-names></name></person-group><article-title>Logistics of community smallpox control through contact tracing and ring vaccination: a stochastic network model</article-title><source>BMC Public Health</source><year>2004</year><volume>4</volume><fpage>34</fpage><pub-id pub-id-type="doi">10.1186/1471-2458-4-34</pub-id><pub-id pub-id-type="pmid">15298713</pub-id></element-citation></ref><ref id="CR17"><label>17.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kretzschmar</surname><given-names>M</given-names></name><name><surname>van den Hof</surname><given-names>S</given-names></name><name><surname>Wallinga</surname><given-names>J</given-names></name><name><surname>van Wijingaarden</surname><given-names>J</given-names></name></person-group><article-title>Ring vaccination and smallpox control</article-title><source>Emerg Infect Dis</source><year>2004</year><volume>10</volume><issue>5</issue><fpage>832</fpage><lpage>841</lpage><pub-id pub-id-type="pmid">15200816</pub-id></element-citation></ref><ref id="CR18"><label>18.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wu</surname><given-names>JT</given-names></name><name><surname>Riley</surname><given-names>S</given-names></name><name><surname>Fraser</surname><given-names>C</given-names></name><name><surname>Leung</surname><given-names>GM</given-names></name></person-group><article-title>Reducing the impact of the next influenza pandemic using household-based public health interventions</article-title><source>PLoS Medicine</source><year>2006</year><volume>3</volume><fpage>1532</fpage><lpage>1540</lpage><pub-id pub-id-type="doi">10.1371/journal.pmed.0030361</pub-id></element-citation></ref><ref id="CR19"><label>19.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hyman</surname><given-names>JM</given-names></name><name><surname>Li</surname><given-names>J</given-names></name><name><surname>Stanley</surname><given-names>EA</given-names></name></person-group><article-title>Modeling the impact of random screening and contact tracing in reducing the spread of HIV</article-title><source>Math Biosci</source><year>2003</year><volume>181</volume><fpage>17</fpage><lpage>54</lpage><pub-id pub-id-type="doi">10.1016/S0025-5564(02)00128-1</pub-id><pub-id pub-id-type="pmid">12421551</pub-id></element-citation></ref><ref id="CR20"><label>20.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Armbruster</surname><given-names>B</given-names></name><name><surname>Brandeau</surname><given-names>ML</given-names></name></person-group><article-title>Optimal mix of screening and contact tracing for endemic diseases</article-title><source>Math Biosci</source><year>2007</year><volume>209</volume><fpage>386</fpage><lpage>402</lpage><pub-id pub-id-type="doi">10.1016/j.mbs.2007.02.007</pub-id><pub-id pub-id-type="pmid">17428503</pub-id></element-citation></ref><ref id="CR21"><label>21.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kretzschmar</surname><given-names>M</given-names></name></person-group><article-title>Sexual network structure and sexually transmitted disease prevention: a modeling perspective</article-title><source>Sex Transm Dis</source><year>2000</year><volume>27</volume><fpage>627</fpage><lpage>635</lpage><pub-id pub-id-type="doi">10.1097/00007435-200011000-00011</pub-id><pub-id pub-id-type="pmid">11099078</pub-id></element-citation></ref><ref id="CR22"><label>22.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>M&#x000fc;ller</surname><given-names>J</given-names></name><name><surname>Kretzschmar</surname><given-names>M</given-names></name><name><surname>Dietz</surname><given-names>K</given-names></name></person-group><article-title>Contact tracing in stochastic and deterministic epidemic models</article-title><source>Math Biosci</source><year>2000</year><volume>164</volume><fpage>39</fpage><lpage>64</lpage><pub-id pub-id-type="doi">10.1016/S0025-5564(99)00061-9</pub-id><pub-id pub-id-type="pmid">10704637</pub-id></element-citation></ref><ref id="CR23"><label>23.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Huerta</surname><given-names>R</given-names></name><name><surname>Tsimring</surname><given-names>LS</given-names></name></person-group><article-title>Contact tracing and epidemics control in social networks</article-title><source>Phys Rev E Stat Nonlin Soft Matter Phys</source><year>2002</year><volume>66</volume><issue>5</issue><fpage>56115</fpage></element-citation></ref><ref id="CR24"><label>24.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Eames</surname><given-names>KTD</given-names></name><name><surname>Keeling</surname><given-names>MJ</given-names></name></person-group><article-title>Contact tracing and disease control</article-title><source>Proc R Soc Lond B Biol Sci</source><year>2003</year><volume>270</volume><fpage>2565</fpage><lpage>2571</lpage><pub-id pub-id-type="doi">10.1098/rspb.2003.2554</pub-id></element-citation></ref><ref id="CR25"><label>25.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dasgupta</surname><given-names>K</given-names></name><name><surname>Schwartzman</surname><given-names>K</given-names></name><name><surname>Marchand</surname><given-names>R</given-names></name><name><surname>Tennenbaum</surname><given-names>TN</given-names></name><name><surname>Brassard</surname><given-names>P</given-names></name><name><surname>Menzies</surname><given-names>D</given-names></name></person-group><article-title>Comparison of cost-effectiveness of tuberculosis screening of close contacts and foreign-born populations</article-title><source>Am J Respir Crit Care Med</source><year>2000</year><volume>162</volume><issue>6</issue><fpage>2079</fpage><lpage>2086</lpage><pub-id pub-id-type="pmid">11112118</pub-id></element-citation></ref><ref id="CR26"><label>26.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Macintyre</surname><given-names>CR</given-names></name><name><surname>Plant</surname><given-names>AJ</given-names></name><name><surname>Hendrie</surname><given-names>D</given-names></name></person-group><article-title>The cost-effectiveness of evidence-based guidelines and practice for screening and prevention of tuberculosis</article-title><source>Health Econ</source><year>2000</year><volume>9</volume><issue>5</issue><fpage>411</fpage><lpage>421</lpage><pub-id pub-id-type="doi">10.1002/1099-1050(200007)9:5&#x0003c;411::AID-HEC524&#x0003e;3.0.CO;2-9</pub-id><pub-id pub-id-type="pmid">10903541</pub-id></element-citation></ref><ref id="CR27"><label>27.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Varghese</surname><given-names>B</given-names></name><name><surname>Peterman</surname><given-names>TA</given-names></name><name><surname>Holtgrave</surname><given-names>DR</given-names></name></person-group><article-title>Cost-effectiveness of counseling and testing and partner notification: a decision analysis</article-title><source>AIDS</source><year>1999</year><volume>13</volume><issue>13</issue><fpage>1745</fpage><lpage>1751</lpage><pub-id pub-id-type="doi">10.1097/00002030-199909100-00019</pub-id><pub-id pub-id-type="pmid">10509577</pub-id></element-citation></ref><ref id="CR28"><label>28.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cohen</surname><given-names>DA</given-names></name><name><surname>Wu</surname><given-names>SY</given-names></name><name><surname>Farley</surname><given-names>TA</given-names></name></person-group><article-title>Comparing the cost-effectiveness of HIV prevention interventions</article-title><source>J Acquir Immune Defic Syndr</source><year>2004</year><volume>37</volume><issue>3</issue><fpage>1404</fpage><lpage>1414</lpage><pub-id pub-id-type="doi">10.1097/01.qai.0000123271.76723.96</pub-id><pub-id pub-id-type="pmid">15483470</pub-id></element-citation></ref><ref id="CR29"><label>29.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Howell</surname><given-names>MR</given-names></name><name><surname>Kassler</surname><given-names>WJ</given-names></name><name><surname>Haddix</surname><given-names>A</given-names></name></person-group><article-title>Partner notification to prevent pelvic inflammatory disease in women: cost-effectiveness of two strategies</article-title><source>Sex Transm Dis</source><year>1997</year><volume>24</volume><issue>5</issue><fpage>287</fpage><lpage>292</lpage><pub-id pub-id-type="doi">10.1097/00007435-199705000-00010</pub-id><pub-id pub-id-type="pmid">9153739</pub-id></element-citation></ref><ref id="CR30"><label>30.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Oxman</surname><given-names>GL</given-names></name><name><surname>Doyle</surname><given-names>L</given-names></name></person-group><article-title>A comparison of the case-finding effectiveness and average costs of screening and partner notification</article-title><source>Sex Transm Dis</source><year>1996</year><volume>23</volume><issue>1</issue><fpage>51</fpage><lpage>57</lpage><pub-id pub-id-type="pmid">8801644</pub-id></element-citation></ref><ref id="CR31"><label>31.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Welte</surname><given-names>R</given-names></name><name><surname>Kretzschmar</surname><given-names>M</given-names></name><name><surname>Postma</surname><given-names>MJ</given-names></name><name><surname>Leidl</surname><given-names>R</given-names></name><name><surname>van den Hoek</surname><given-names>JAR</given-names></name><name><surname>Jager</surname><given-names>JC</given-names></name><name><surname>Postma</surname><given-names>MJ</given-names></name></person-group><article-title>Cost-effectiveness of screening programs for chlamydia trachomatis: a population based dynamic approach</article-title><source>Sex Transm Dis</source><year>2000</year><volume>27</volume><fpage>518</fpage><lpage>529</lpage><pub-id pub-id-type="doi">10.1097/00007435-200010000-00005</pub-id><pub-id pub-id-type="pmid">11034526</pub-id></element-citation></ref><ref id="CR32"><label>32.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Watts</surname><given-names>DJ</given-names></name><name><surname>Strogatz</surname><given-names>SH</given-names></name></person-group><article-title>Collective dynamics of &#x02018;small-world&#x02019; networks</article-title><source>Nature</source><year>1998</year><volume>393</volume><fpage>440</fpage><lpage>442</lpage><pub-id pub-id-type="doi">10.1038/30918</pub-id><pub-id pub-id-type="pmid">9623998</pub-id></element-citation></ref><ref id="CR33"><label>33.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schneeberger</surname><given-names>A</given-names></name><name><surname>Mercer</surname><given-names>CH</given-names></name><name><surname>Gregson</surname><given-names>SA</given-names></name><name><surname>Ferguson</surname><given-names>NM</given-names></name><name><surname>Nyamukapa</surname><given-names>CA</given-names></name><name><surname>Anderson</surname><given-names>RM</given-names></name><name><surname>Johnson</surname><given-names>AM</given-names></name><name><surname>Garnett</surname><given-names>GP</given-names></name></person-group><article-title>Scale-free networks and sexually transmitted diseases: a description of observed patterns of sexual contacts in Britain and Zimbabwe</article-title><source>Sex Transm Dis</source><year>2004</year><volume>31</volume><issue>6</issue><fpage>380</fpage><lpage>387</lpage><pub-id pub-id-type="doi">10.1097/00007435-200406000-00012</pub-id><pub-id pub-id-type="pmid">15167650</pub-id></element-citation></ref><ref id="CR34"><label>34.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Klovdahl</surname><given-names>AS</given-names></name><name><surname>Potterat</surname><given-names>JJ</given-names></name><name><surname>Woodhouse</surname><given-names>DE</given-names></name><name><surname>Muth</surname><given-names>JB</given-names></name><name><surname>Muth</surname><given-names>SQ</given-names></name><name><surname>Darrow</surname><given-names>WW</given-names></name></person-group><article-title>Social networks and infectious disease: the Colorado Springs study</article-title><source>Soc Sci Med</source><year>1994</year><volume>38</volume><issue>1</issue><fpage>79</fpage><lpage>88</lpage><pub-id pub-id-type="doi">10.1016/0277-9536(94)90302-6</pub-id><pub-id pub-id-type="pmid">8146718</pub-id></element-citation></ref><ref id="CR35"><label>35.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Weeks</surname><given-names>MR</given-names></name><name><surname>Clair</surname><given-names>S</given-names></name><name><surname>Borgatti</surname><given-names>SP</given-names></name><name><surname>Radda</surname><given-names>K</given-names></name><name><surname>Schensul</surname><given-names>JJ</given-names></name></person-group><article-title>Social networks of drug users in high-risk sites: finding the connections</article-title><source>AIDS Behav</source><year>2002</year><volume>6</volume><issue>2</issue><fpage>194</fpage><lpage>206</lpage><pub-id pub-id-type="doi">10.1023/A:1015457400897</pub-id></element-citation></ref><ref id="CR36"><label>36.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Parker</surname><given-names>M</given-names></name><name><surname>Ward</surname><given-names>H</given-names></name><name><surname>Day</surname><given-names>S</given-names></name></person-group><article-title>Sexual networks and the transmission of HIV in London</article-title><source>J Biosoc Sci</source><year>1998</year><volume>30</volume><fpage>63</fpage><lpage>83</lpage><pub-id pub-id-type="doi">10.1017/S0021932098000637</pub-id><pub-id pub-id-type="pmid">9746814</pub-id></element-citation></ref><ref id="CR37"><label>37.</label><mixed-citation publication-type="other">Helleringer&#x000a0;S, Kohler&#x000a0;HP, Chimbiri&#x000a0;A, Chatonda&#x000a0;P, Mkandawire&#x000a0;J (2007) The Likoma network study: context, data collection and survey instruments. URL: <ext-link ext-link-type="uri" xlink:href="http://www.ssc.upenn.edu/~hpkohler/working-papers/hell06likdoc.pdf">http://www.ssc.upenn.edu/~hpkohler/working-papers/hell06likdoc.pdf</ext-link>. Working paper</mixed-citation></ref><ref id="CR38"><label>38.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wylie</surname><given-names>JL</given-names></name><name><surname>Jolly</surname><given-names>A</given-names></name></person-group><article-title>Patterns of chlamydia and gonorrhea infection in sexual networks in Manitoba, Canada</article-title><source>Sex Transm Dis</source><year>2001</year><volume>28</volume><issue>1</issue><fpage>14</fpage><lpage>24</lpage><pub-id pub-id-type="doi">10.1097/00007435-200101000-00005</pub-id><pub-id pub-id-type="pmid">11196040</pub-id></element-citation></ref><ref id="CR39"><label>39.</label><mixed-citation publication-type="other">Armbruster&#x000a0;B, Brandeau&#x000a0;ML (2007) Who do you know? A simulation study of infectious disease control through contact tracing. In: Proceedings of the 2007 Western Multiconference on Computer Simulation, pp 79&#x02013;85</mixed-citation></ref><ref id="CR40"><label>40.</label><mixed-citation publication-type="other">Gold&#x000a0;M, Siegel&#x000a0;J, Russell&#x000a0;L, Weinstein&#x000a0;M (1996) Cost-effectiveness in health and medicine. Oxford Univ. Press</mixed-citation></ref><ref id="CR41"><label>41.</label><mixed-citation publication-type="other">National Institutes of Health (2001) Workshop summary: scientific evidence on condom effectiveness for sexually transmitted disease (STD) prevention. URL: <ext-link ext-link-type="uri" xlink:href="http://www.niaid.nih.gov/dmid/stds/condomreport.pdf">http://www.niaid.nih.gov/dmid/stds/condomreport.pdf</ext-link></mixed-citation></ref><ref id="CR42"><label>42.</label><mixed-citation publication-type="other">Centers for Disease Control and Prevention (2006) Fact sheet: gonorrhea. URL: <ext-link ext-link-type="uri" xlink:href="http://www.cdc.gov/std/Gonorrhea/STDFact-gonorrhea.htm">http://www.cdc.gov/std/Gonorrhea/STDFact-gonorrhea.htm</ext-link></mixed-citation></ref><ref id="CR43"><label>43.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mehta</surname><given-names>SD</given-names></name><name><surname>Bishai</surname><given-names>D</given-names></name><name><surname>Howell</surname><given-names>MR</given-names></name><name><surname>Rothman</surname><given-names>RE</given-names></name><name><surname>Quinn</surname><given-names>TC</given-names></name><name><surname>Zenilman</surname><given-names>JM</given-names></name></person-group><article-title>Cost-effectiveness of five strategies for gonorrhea and chlamydia control among female and male emergency department patients</article-title><source>Sex Transm Dis</source><year>2002</year><volume>29</volume><issue>2</issue><fpage>83</fpage><lpage>91</lpage><pub-id pub-id-type="doi">10.1097/00007435-200202000-00004</pub-id><pub-id pub-id-type="pmid">11818893</pub-id></element-citation></ref><ref id="CR44"><label>44.</label><mixed-citation publication-type="other">Centers for Disease Control and Prevention (2001) Program evaluation. URL: <ext-link ext-link-type="uri" xlink:href="http://www.cdc.gov/std/program/training/TOC-PGtraining.htm">http://www.cdc.gov/std/program/training/TOC-PGtraining.htm</ext-link></mixed-citation></ref><ref id="CR45"><label>45.</label><mixed-citation publication-type="other">Neumann&#x000a0;P, et&#x000a0;al. (2001) Preference weights 1998&#x02013;2001. URL: <ext-link ext-link-type="uri" xlink:href="http://www.tufts-nemc.org/cearegistry/data/docs/phaseIIpreferenceweights.pdf">http://www.tufts-nemc.org/cearegistry/data/docs/phaseIIpreferenceweights.pdf</ext-link></mixed-citation></ref><ref id="CR46"><label>46.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Owens</surname><given-names>DK</given-names></name></person-group><article-title>Interpretation of cost-effectiveness analyses</article-title><source>J Gen Intern Med</source><year>1998</year><volume>13</volume><fpage>716</fpage><lpage>717</lpage><pub-id pub-id-type="doi">10.1046/j.1525-1497.1998.00211.x</pub-id><pub-id pub-id-type="pmid">9798822</pub-id></element-citation></ref><ref id="CR47"><label>47.</label><mixed-citation publication-type="other">U.S. Citizenship and Immigration Services (2006) Medical examinations. URL: <ext-link ext-link-type="uri" xlink:href="http://www.uscis.gov/propub/ProPubVAP.jsp?dockey=1c56d78b831659735c9fd1c1f7dbd68f">http://www.uscis.gov/propub/ProPubVAP.jsp?dockey=1c56d78b831659735c9fd1c1f7dbd68f</ext-link></mixed-citation></ref><ref id="CR48"><label>48.</label><mixed-citation publication-type="other">Citizenship and Immigration Canada (2002) Fact sheet&#x02014;medical testing and surveillance. URL: <ext-link ext-link-type="uri" xlink:href="http://www.cic.gc.ca/english/pub/fs-medical.html">http://www.cic.gc.ca/english/pub/fs-medical.html</ext-link></mixed-citation></ref><ref id="CR49"><label>49.</label><mixed-citation publication-type="other">World Health Organization (2001) Global prevalence and incidence of selected curable sexually transmitted infections: overview and estimates. URL: <ext-link ext-link-type="uri" xlink:href="http://www.who.int/docstore/hiv/GRSTI/index.htm">http://www.who.int/docstore/hiv/GRSTI/index.htm</ext-link></mixed-citation></ref><ref id="CR50"><label>50.</label><element-citation publication-type="journal"><person-group person-group-type="author"><collab>Centers for Disease Control and Prevention</collab></person-group><article-title>Revised recommendations for HIV testing of adults, adolescents, and pregnant women in health-care settings</article-title><source>MMWR</source><year>2006</year><volume>55</volume><issue>RR14</issue><fpage>1</fpage><lpage>17</lpage></element-citation></ref><ref id="CR51"><label>51.</label><mixed-citation publication-type="other">Webb&#x000a0;AL (2004) But I didn&#x02019;t know..., 2004. Philadelphia City Paper January 22</mixed-citation></ref><ref id="CR52"><label>52.</label><mixed-citation publication-type="other">Centers for Disease Control and Prevention (2005) STD surveillance 2005 national profile&#x02014;chlamydia. URL: <ext-link ext-link-type="uri" xlink:href="http://www.cdc.gov/std/stats/chlamydia.htm">http://www.cdc.gov/std/stats/chlamydia.htm</ext-link></mixed-citation></ref><ref id="CR53"><label>53.</label><mixed-citation publication-type="other">National Institutes of Health (2006) Chlamydia. URL: <ext-link ext-link-type="uri" xlink:href="http://www.niaid.nih.gov/factsheets/stdclam.htm">http://www.niaid.nih.gov/factsheets/stdclam.htm</ext-link></mixed-citation></ref><ref id="CR54"><label>54.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zimmerman</surname><given-names>HL</given-names></name><name><surname>Potterat</surname><given-names>JJ</given-names></name><name><surname>Dukes</surname><given-names>RL</given-names></name><name><surname>Muth</surname><given-names>JB</given-names></name><name><surname>Zimmerman</surname><given-names>HP</given-names></name><name><surname>Fogle</surname><given-names>JS</given-names></name><name><surname>Pratts</surname><given-names>CI</given-names></name></person-group><article-title>Epidemiologic differences between chlamydia and gonorrhea</article-title><source>Am J Public Health</source><year>1990</year><volume>80</volume><issue>11</issue><fpage>1338</fpage><lpage>1342</lpage><pub-id pub-id-type="doi">10.2105/AJPH.80.11.1338</pub-id><pub-id pub-id-type="pmid">2240301</pub-id></element-citation></ref><ref id="CR55"><label>55.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hu</surname><given-names>D</given-names></name><name><surname>Hook</surname><given-names>EW</given-names><suffix>3rd</suffix></name><name><surname>Goldie</surname><given-names>SJ</given-names></name></person-group><article-title>Screening for Chlamydia trachomatis in women 15 to 29 years of age: a cost-effectiveness analysis</article-title><source>Ann Intern Med</source><year>2004</year><volume>141</volume><fpage>501</fpage><lpage>513</lpage><pub-id pub-id-type="pmid">15466767</pub-id></element-citation></ref><ref id="CR56"><label>56.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kaplan</surname><given-names>EH</given-names></name><name><surname>Craft</surname><given-names>DL</given-names></name><name><surname>Wein</surname><given-names>LM</given-names></name></person-group><article-title>Emergency response to a smallpox attack: the case for mass vaccination</article-title><source>PNAS</source><year>2002</year><volume>99</volume><issue>16</issue><fpage>10935</fpage><lpage>10940</lpage><pub-id pub-id-type="doi">10.1073/pnas.162282799</pub-id><pub-id pub-id-type="pmid">12118122</pub-id></element-citation></ref><ref id="CR57"><label>57.</label><element-citation publication-type="journal"><person-group person-group-type="author"><collab>Centers for Disease Control and Prevention</collab></person-group><article-title>Extensively drug-resistant tuberculosis&#x02014;United States, 1993&#x02013;2006</article-title><source>MMWR</source><year>2007</year><volume>56</volume><issue>11</issue><fpage>250</fpage><lpage>253</lpage><pub-id pub-id-type="pmid">17380107</pub-id></element-citation></ref><ref id="CR58"><label>58.</label><element-citation publication-type="journal"><person-group person-group-type="author"><collab>Centers for Disease Control and Prevention</collab></person-group><article-title>Update to CDC&#x02019;s sexually transmitted diseases treatment guidelines, 2006: fluoroquinolones no longer recommended for treatment of gonococcal infections</article-title><source>MMWR</source><year>2007</year><volume>56</volume><issue>14</issue><fpage>332</fpage><lpage>336</lpage><pub-id pub-id-type="pmid">17431378</pub-id></element-citation></ref></ref-list></back></article>